Inflammatory and endothelial dysfunction markers in females with metabolic syndrome aged 50–75 years

Authors

  • Pusparini Department of Clinical Pathology, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia https://orcid.org/0000-0002-3371-5825
  • Raditya Wratsangka Department of Obstetrics Gynecology, Faculty of Medicine, Unviersitas Trisakti, Jakarta, Indonesia https://orcid.org/0000-0001-6254-8336
  • Merijanti Lie Tanu Department of Occupational Medicine, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
  • Meiyanti Department of Pharmacology and Pharmacy, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia https://orcid.org/0000-0002-1770-5504
  • Rismawati Yaswir Department of Clinical Pathology, Faculty of Medicine, Andalas University, Padang, Indonesia

DOI:

https://doi.org/10.17532/jhsci.2023.2003

Keywords:

Ferritin, high-sensitive C-reactive protein, intercellular cell adhesion molecule-1, inflammation, metabolic syndrome, pentraxin-3

Abstract

Introduction: The prevalence of metabolic syndrome (MetS) in Indonesia is 39% and it is higher in females than in males (46% vs. 28%). Features of this syndrome comprise low-grade chronic inflammation and endothelial dysfunction from cardiometabolic abnormalities. High-sensitive C-reactive protein (HsCRP) is a biomarker of cardiovascular disease, whereas ferritin and pentraxin-3 (PTX-3) are markers of chronic inflammation. One of the markers of endothelial dysfunction is an intercellular cell adhesion molecule-1 (ICAM-1). Studies on MetS in women aged 50–70 years and using several markers of inflammation and endothelial dysfunction are rare. The study aimed to determine differences in HsCRP, ferritin, PTX-3, and ICAM-1 level between females with and without MetS aged 50–75 years.

Methods: For this cross-sectional study, 160 females aged 50–75 years from South Jakarta were recruited, divided into MetS and non-MetS (control) groups, 80 participants each. Participants that met the inclusion criteria were assessed for vital signs and metabolic parameters (e.g., lipid profile, fasting blood glucose level, and waist circumference [WC]). The groups were compared using an independent t-test for inflammatory (i.e., HsCRP, PTX-3, and ferritin) and endothelial dysfunction (ICAM-1) (p < 0.05) biomarkers.

Results: The mean age of the MetS and control groups was 59.6 ± 5.6 and 59.2 ± 5.5 years. MetS criteria included WC of ≥80 cm (95.2%), increased blood pressure level (90.6%); and high-density lipoprotein cholesterol of <50 mg/dL (76.2%). Significant differences were found between the MetS and control groups for ferritin (p = 0.027), PTX-3 (p = 0.045), and ICAM-1 (p = 0.004) but not for HsCRP (p = 0.136).

Conclusion: Elevated ferritin, PTX-3 level, and ICAM-1 level are significantly associated with an increased Mets risk in females aged 50–75 years; however, the same is not true for HsCRP.


Downloads

Download data is not yet available.

Downloads

Published

30.09.2023

Issue

Section

Research articles

Categories

How to Cite

1.
Inflammatory and endothelial dysfunction markers in females with metabolic syndrome aged 50–75 years. JHSCI [Internet]. 2023 Sep. 30 [cited 2024 May 24];13(2):84-90. Available from: https://www.jhsci.ba/ojs/index.php/jhsci/article/view/2003